Supernus Pharmaceuticals, Inc. (SUPN) quarterly cash flow statement — complete operating, investing & financing history
Supernus Pharmaceuticals, Inc. (SUPN) cash flow statement — 18-year operating, investing & financing cash flows
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Cash from Operations | 97M | 229M | -9M | -221M | -39M | 158M | 75M | -5M | 2M | 88M | 38.4M | 44.96M | 35.88M | -18.87M | 49.13M | 27.56M | 13.84M | 71.12M | 4.3M | 48.76M |
| Operating CF Margin % | 27.25% | 66.76% | -2.84% | -61.73% | -12.42% | 52.32% | 28.2% | -1.67% | 0.65% | 29.43% | 26.73% | 27.36% | 23.31% | -13.92% | 31.95% | 16.47% | 7.8% | 41.82% | 2.82% | 30.66% |
| Operating CF Growth % | 348.72% | 44.94% | -112% | -4320% | -2050% | 79.55% | 95.31% | -111.12% | -94.43% | 566.25% | -21.83% | 63.1% | 159.19% | -126.54% | 1041.93% | -43.47% | 436.76% | 53.69% | -88.12% | 52.7% |
| Net Income | 137M | 122M | 89M | 102M | 43M | 18M | 47M | 66M | 22M | -97M | 124K | 1.18M | -15.98M | -831K | 16.95M | 25.48M | 1.75M | 7.87M | 25.62M | 2.44M |
| Depreciation & Amortization | 1M | 3M | 4M | 5M | 5M | 5M | 5M | 5M | 8M | 6M | 20.75M | 21.68M | 21.86M | 20.73M | 20.6M | 20.85M | 21.77M | 21.56M | 21.36M | 12.71M |
| Stock-Based Compensation | 8M | 11M | 9M | 5M | 7M | 8M | 6M | 6M | 6M | 6M | 5.9M | 6.45M | 7.92M | 6.09M | 6.31M | 4.26M | 4.99M | 4.3M | 4.03M | 4.04M |
| Deferred Taxes | -17M | 25M | 27M | -38M | -15M | 0 | 0 | 0 | 0 | 0 | -5.48M | -10.46M | -9.27M | -5.55M | -435K | -7.76M | -2.51M | -3.05M | -13.01M | -4.51M |
| Other Non-Cash Items | 4M | 4M | 25M | 4M | 18M | 6M | -1M | 42M | 4M | -17M | 3.25M | 24.15M | 1.67M | 6.9M | 288K | 1.8M | 12.33M | 1.41M | -11.97M | 5.32M |
| Working Capital Changes | -36M | 64M | -163M | -299M | -97M | 121M | 18M | -124M | -38M | 190M | 13.87M | 1.97M | 29.67M | -46.2M | 5.42M | -17.07M | -24.49M | 39.03M | -21.72M | 28.77M |
| Change in Receivables | -2M | 20M | -20M | 6M | -18M | 4M | 11M | -4M | 9M | -10M | -3.58M | -2.39M | -5.21M | 4.39M | 21.97M | -1.41M | -5.87M | -12.9M | 3.81M | -3.48M |
| Change in Inventory | 1M | 1M | -1M | 2M | -6M | 17M | 5M | -9M | -6M | -8M | 1.99M | 5.03M | 6.91M | -3.98M | -1.85M | -11.55M | -8.15M | 4.31M | -2.47M | -5.25M |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10.02M | -269K | -6.09M | -19.38M | -10.55M | -6.5M | -24.42M | 41.24M | -29.48M | 33.91M |
| Cash from Investing | -14M | -8M | -19M | -24M | -20M | -17M | -5M | 10M | 35M | 1M | -51.62M | -65.98M | 34.63M | 60.3M | 239.78M | -48.77M | -82.23M | -15.68M | -69.99M | 76.13M |
| Capital Expenditures | -14M | -7M | -20M | -24M | -20M | -17M | -5M | -16M | -7M | -4M | -248K | 36K | -150K | -159K | -278K | 861K | -147K | 576K | -851K | -40K |
| CapEx % of Revenue | 3.93% | 2.04% | 6.31% | 6.7% | 6.37% | 5.63% | 1.88% | 5.35% | 2.28% | 1.34% | 0.17% | 0.02% | 0.1% | 0.12% | 0.18% | 0.51% | 0.08% | 0.34% | 0.56% | 0.03% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 82.08M | 0 | 0 | -310.74M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -1M | 0 | 0 | 0 | 1M | -1M | 0 | 1M | -1M | 0 | 0 | 0 | 0 | 0 | -851K | -82.08M | 0 | 0 | 12.89M |
| Cash from Financing | -254.11K | -173M | 7M | -5M | -3M | -5M | -17M | 27M | -51M | -35M | 1.57M | 1.09M | -230K | -478.92M | 80.17M | 2.83M | 6.46M | 2.27M | -22.03M | -136.74M |
| Debt Issued (Net) | 231.15K | 0 | 156M | -5M | -4M | -4M | -4M | 101M | -1M | 0 | 0 | 0 | 0 | -480.86M | 78.36M | 0 | 0 | 0 | 0 | -138.31M |
| Equity Issued (Net) | -462.3K | -176M | -147M | -2M | 2M | -1M | -13M | -50M | -49M | -36M | 2.91M | 3.08M | 740K | 2.52M | 2.26M | 2.83M | 6.46M | 2.27M | 866K | 1.57M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -462.3K | -176M | -126M | 0 | 0 | 0 | -11M | -51M | -51M | -35M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -22.96K | 3M | -2M | 2M | -1M | 0 | 0 | -24M | -1M | 1M | -1.34M | -1.99M | -970K | -575K | -445K | 0 | 0 | 0 | -22.9M | 0 |
| Net Change in Cash | 83M | 48M | -20M | -250M | -64M | 137M | 53M | 31M | -14M | 54M | -11.65M | -19.93M | 70.28M | -437.49M | 369.08M | -18.37M | -61.94M | 57.71M | -87.72M | -11.85M |
| Free Cash Flow | 83M | 222M | -29M | -245M | -59M | 140M | 70M | -21M | -5M | 84M | 38.15M | 44.99M | 35.73M | -19.03M | 48.85M | 28.43M | 13.69M | 71.69M | 3.45M | 48.72M |
| FCF Margin % | 23.31% | 64.72% | -9.15% | -68.44% | -18.79% | 46.36% | 26.32% | -7.02% | -1.63% | 28.09% | 26.56% | 27.38% | 23.22% | -14.04% | 31.77% | 16.99% | 7.72% | 42.16% | 2.26% | 30.63% |
| FCF Growth % | 240.68% | 58.57% | -141.43% | -1066.67% | -1080% | 66.67% | 83.47% | -146.67% | -114% | 541.34% | -21.89% | 58.29% | 160.88% | -126.55% | 1315.47% | -41.66% | 429.66% | 54.94% | -90.05% | 53.61% |
| FCF per Share | 0.68 | 1.72 | -0.22 | -1.96 | -0.46 | 1.13 | 0.57 | -0.16 | -0.04 | 0.62 | 0.69 | 0.82 | 0.65 | -0.35 | 0.78 | 0.46 | 0.25 | 1.17 | 0.06 | 0.89 |
| FCF Conversion (FCF/Net Income) | 0.71x | 1.88x | -0.10x | -2.17x | -0.93x | 8.78x | 1.60x | -0.08x | 0.50x | -0.91x | 309.69x | 38.26x | -2.25x | 22.71x | 2.90x | 1.08x | 7.91x | 9.04x | 0.17x | 19.97x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.95M | 0 | 0 | 1.26M | 0 | 1.26M | 629K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 336K | 9.55M | 6.62M | 20.23M | 203K | 1.64M | 6.01M | 0 | 478K | 79K |